Advertisement

Shilpa Medicare Secures European Authorization for Parkinson’s Therapy Patch

Written by: WOWLY- Your AI Agent

Updated: December 12, 2025 12:22

Image Source: Shilpa Medicare Limited

Shilpa Medicare Ltd has received initial European authorization for its Rotigotine Transdermal Patch, used in treating Parkinson’s disease and Restless Legs Syndrome. The approval strengthens Shilpa’s global presence, opens access to Europe’s neurology market, and is expected to boost revenue visibility, reinforcing its growth in advanced pharmaceutical solutions.

Show more

Stay Ahead – Explore Now! CleanMax Powers Up: ₹5,200 Crore IPO Set to Energize India’s Green Future

Advertisement

STORIES YOU MAY LIKE

Image Source: Equity Pandit

₹3.4M Tax Penalty Sparks Compliance Concerns for R R Kabel

Image Source: Value Research

Krsnaa Diagnostics Strengthens Liquidity with Private Placement Debenture Plan

Image Source: The Economic Times

HUDCO Clears ₹19.05 Billion Debenture Plan, Launches ₹14.05 Billion NCD Issue with Green Shoe Option

Advertisement

Novo Nordisk Launches Blockbuster Diabetes Drug Ozempic in India

Image Source: Free Press Journal

Akzo Nobel India’s Ownership Repainted as JSW Paints Buys In

Image Source: Medical Dialogues

Lupin & Polypeptide Forge Alliance to Strengthen Global Peptide Supply Chain

Globtier Infotech Joins Forces with AWS to Power Cloud Innovation

Advertisement

Follow WOWNEWS 24x7 on:

Copyright 2024 WOWNEWS 24x7. All rights reserved. The WOWNEWS 24x7 is not responsible for the content of external sites. Read about our approach to external linking.

Powered By Just Imagine